☰

Yanir Shaked, Ph.D. - Publications

Affiliations: 
2008 University of Massachusetts Lowell, Lowell, MA, United States 
Area:
Plastics Technology
Tree Info Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Hasnis E, Alishekevitz D, Gingis-Veltski S, Bril R, Fremder E, Voloshin T, Raviv Z, Karban A, Shaked Y. Anti-Bv8 antibody and metronomic gemcitabine improve pancreatic adenocarcinoma treatment outcome following weekly gemcitabine therapy. Neoplasia (New York, N.Y.). 16: 501-10. PMID 24957319 DOI: 10.1016/j.neo.2014.05.011  0.302
2014 Alishekevitz D, Bril R, Loven D, Miller V, Voloshin T, Gingis-Velistki S, Fremder E, Scherer SJ, Shaked Y. Differential therapeutic effects of anti-VEGF-A antibody in different tumor models: implications for choosing appropriate tumor models for drug testing. Molecular Cancer Therapeutics. 13: 202-13. PMID 24150126 DOI: 10.1158/1535-7163.MCT-13-0356  0.308
2009 Daenen LG, Shaked Y, Man S, Xu P, Voest EE, Hoffman RM, Chaplin DJ, Kerbel RS. Low-dose metronomic cyclophosphamide combined with vascular disrupting therapy induces potent antitumor activity in preclinical human tumor xenograft models. Molecular Cancer Therapeutics. 8: 2872-81. PMID 19825805 DOI: 10.1158/1535-7163.Mct-09-0583  0.312
2007 Shaked Y, Kerbel RS. Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy. Cancer Research. 67: 7055-8. PMID 17671170 DOI: 10.1158/0008-5472.Can-07-0905  0.309
Show low-probability matches.